Dell technologies and i2b2 transmart foundation create "digital twins" to treat long-haul covid-19

Round rock, texas, may 5, 2021 /prnewswire/ --  news summary covid-19 long haulers study to create personalized health risk scores and drug treatment recommendations based on patients' unique medical history and genetics ai-driven research and digital twins will support hospitals and research centers globally and contribute to dell's goal to use technology and scale to advance health, education and economic opportunity for 1 billion people by 2030 full story dell technologies (nyse:dell) is helping i2b2 transmart foundation, a non-profit open-source research organization, mobilize huge amounts of global de-identified patient data to create virtual models of patients – known as digital twins – to treat impacts of long-haul covid-19. through dell technologies' modern infrastructure, the i2b2 transmart community will use de-identified patient data to produce digital twins.
DELL Ratings Summary
DELL Quant Ranking